von Willebrand factor/factor VIII concentrate (Haemate P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery.

Lethagen, S; Kyrle, P A; Castaman, G; Haertel, S; Mannucci, P M

Lethagen, S; Kyrle, P A; Castaman, G; Haertel, S; Mannucci, P M.

Affiliation

Lethagen S; Department for Coagulation Disorders, University Hospital Malmö, Malmö, Sweden. stefan.lethagen@rh.dk

J Thromb Haemost ; 5(7): 1420-30, 2007 Jul.

Article in En | MEDLINE | ID: mdl-17439628

Subject(s)

Factor VIII/administration & dosage; von Willebrand Diseases/drug therapy; von Willebrand Factor/administration & dosage; Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Factor VIII/adverse effects; Factor VIII/pharmacokinetics; Female; Hemostasis, Surgical; Humans; Male; Middle Aged; Prospective Studies; von Willebrand Diseases/blood; von Willebrand Diseases/surgery; von Willebrand Factor/adverse effects; von Willebrand Factor/pharmacokinetics

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Von Willebrand Diseases / Factor VIII / Von Willebrand Factor Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2007 Type: Article Affiliation country: Sweden

Search on Google

XML

PubMed Links